Starpharma, an Australian bio-tech firm has developed the antiviral Viva Gel, the active ingredient designed to tackle se'xually transmitted infections, in the condom’s lubricant.
The cond'om, which is the first of its kind, would be available to buy in the coming months. The condoms are lubricated with VivaGel, which contains 0.5per cent astodrimer sodium – a non-antibiotic, antimicrobial drug designed specifically as a compound against HIV.
The product has now received a receipt of Conformity of Assessment Certification by the Australian Therapeutic Goods Administration, which paves the way for mass production.
With the imminent public release, the gel would help reduce the transmission of HIV and other STIs, while also reducing the risk of pregnancy.
Starpharma partnered with Ansell, which is responsible for around 70 per cent of Australia’s condom market, to create to the new line of Antiviral gel condoms. The recent TGA approval came after the condom was assessed in line with a set of requirements relating to safety and performance.
Peter Carroll, Ansell president, said consumers could expect to see the ‘ground-breaking new se'xual health’ product on the shelves soon.
He said, ‘Ansell looks forward to rolling out its marketing and sales campaign to support the launch of LifeStyles Dual Protect over the coming months with the first product expected to be available on shelves soon.’
Hmmmn!
ReplyDelete